Media Coverage
June 24th, 2022

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Media Coverage
April 13th, 2022

CytoReason expands reach in Asia, leveraging ML in drug development for Korean drugmakers

Media Coverage
April 12th, 2022

Israel’s CytoReason, S. Korea’s Helixrus partner on machine learning for drug development

Media Coverage
March 29th, 2022

Poolbeg signs deal with Cytoreason on influenza drug development

Media Coverage
March 25th, 2022

Japanese Pharmaceutical Company Uses Israel’s CytoReason For AI Drug Development

Media Coverage
March 24th, 2022

Poolbeg Pharma signs first of its kind AI deal with CytoReason

Bring your data to life